2023
54 COVID-19 and Dialysis Patients
Silberzweig J, Kliger A. 54 COVID-19 and Dialysis Patients. 2023, 491-496. DOI: 10.1016/b978-0-323-79135-9.00054-9.ChaptersDialysis therapyIntermittent renal replacement therapyCOVID-19Continuous dialysis therapyAcute kidney injuryChronic kidney diseaseRenal replacement therapyAcute peritoneal dialysisAssociated risk factorsHome dialysis therapiesHigh rateDepartment of HealthKidney injuryDiabetes mellitusDialysis patientsFacility patientsPeritoneal dialysisKidney diseaseReplacement therapyDialysis programRisk factorsSevere diseaseMedical conditionsSubstantial burdenPatients
1999
Effect of Duration of Chronic Peritoneal Dialysis Therapy on the Development of Peritonitis
Troidle L, Gorban–Brennan N, Kliger A, Finkelstein F. Effect of Duration of Chronic Peritoneal Dialysis Therapy on the Development of Peritonitis. Advances In Peritoneal Dialysis 1999, 19: 376-379. PMID: 10507821, DOI: 10.1177/089686089901900416.Peer-Reviewed Original ResearchConceptsDevelopment of peritonitisChronic peritoneal dialysis therapyCPD therapyGroup of patientsPeritoneal dialysis therapyGroup 1Group 3Group 2Dialysis therapyStudy periodCharts of patientsPeripheral vascular diseaseEpisodes of peritonitisOnset of peritonitisCoronary artery diseaseIncidence of deathRate of peritonitisOut-patient unitPeritoneal macrophage functionStaphylococcus aureus peritonitisPeritoneal membrane structureSpectrum of organismsArtery diseaseDiabetes mellitusRetrospective review
1996
Nine episodes of CPD-associated peritonitis with vancomycin resistant enterococci
Troidle L, Kliger A, Gorban-Brennan N, Fikrig M, Golden M, Finkelstein F. Nine episodes of CPD-associated peritonitis with vancomycin resistant enterococci. Kidney International 1996, 50: 1368-1372. PMID: 8887301, DOI: 10.1038/ki.1996.451.Peer-Reviewed Case Reports and Technical NotesConceptsVancomycin-resistant enterococciCPD therapyResistant enterococciChronic peritoneal dialysisEpisodes of peritonitisCephalosporin therapyPatient monthsTenckhoff catheterCPD patientsDiabetes mellitusOptimal therapyPeritoneal dialysisMean ageAntimicrobial therapyVRE carriageCardiovascular diseaseDialysis unitsGastrointestinal diseasesCertain demographic dataPeritonitisCase controlPatientsDemographic dataTherapyCatheter